With treatment, many people with chronic myeloid leukemia can achieve long-term remission, but a complete cure may not be guaranteed
Chronic myeloid leukemia (CML) is a type of leukemia involving the overproduction of abnormal white blood cells. Treatment often involves targeted therapy with tyrosine kinase inhibitors and, in some cases, stem cell transplantation.
Cancer of the blood and bone marrow, characterized by the overproduction of immature white blood cells (myeloid cells)
Fatigue, weight loss, night sweats, enlarged spleen and liver
Blood tests, bone marrow biopsy, molecular testing
Variable, depends on the stage and response to treatment
Complications related to leukemia and treatment
Genetic mutation (Philadelphia chromosome) resulting in the abnormal fusion of genes
Targeted therapy (tyrosine kinase inhibitors), chemotherapy, stem cell transplant
Targeted therapy (tyrosine kinase inhibitors), chemotherapy, stem cell transplant
Cancer of the blood and bone marrow, characterized by the presence of the Philadelphia chromosome
Tyrosine kinase inhibitors, stem cell transplant as needed
For personalized advice and care, always seek the assistance of healthcare professionals. This information is meant for general understanding and not as a replacement for professional medical advice.
Share: